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SUMMARY
The effect of monensin, a monovalent ionophore, on La Crosse virus particle formation and polypeptide synthesis was examined. Monensin inhibited the release of virus particles (both infectious and non-infectious) from infected BHK-21 cells. Monensin had no detectable effect on the synthesis of polypeptides G1, G2 and N.
Purified virions of La Crosse (LAC) virus, a member of the California encephalitis serogroup of the Bunyaviridae, possess two major glycoproteins (G 1, mol. wt. 120 × 103, and G2, mol. wt. 34 × 103) , a major, non-glycosylated, nucleocapsid protein (N, mol. wt. 23 x 103) and a minor high molecular weight polypeptide (L, mol. wt. 190 × 103) (Obijeski et al., 1976) . The control of synthesis of these polypeptides and their assembly into virus particles has not been fully elucidated. Pennington et al. (1977) demonstrated that during infection of BSC-1 cells by Bunyamwera virus (a virus in the same genus as LAC virus but serologically distinct) the synthesis of the virus-induced polypeptides exhibited temporal regulation. The mechanism by which these polypeptides are then incorporated into virus particles is not known. In the work presented here LAC virus maturation in the presence of monensin, a monovalent ionophore, has been examined. In eukaryotic cells monensin has been reported to interfere with the fusion of Golgi vesicles and the plasmalemma (Tartakoff & Vassalli, 1977 , 1978 . Johnson & Schlesinger (1980) showed with vesicular stomatitis virus (VSV) and Sindbis virus (SV) that monensin inhibited virus particle release from infected cells. Both of these viruses mature by budding at the Plasma membrane unlike LAC virus and other bunyaviruses which mature by budding into the intracytoplasmic vesicles of the Golgi complex (Murphy et al., 1968; Holmes, 1971) . The activity of monensin on virus replication was compared with tunicamycin, a specific inhibitor of glycosylation, which prevents bunyavirus particle formation by inhibiting glycosylation of G1 and G2 (Takatsuki et al., 1975; Cash et al., 1980) . La Crosse virus was obtained from Dr C. R. Pringle, MRC Virology Unit, Glasgow. The virus was cloned three times in BHK-21 cells before use in the experiments described here. Infectious virus was assayed by plaque formation in monolayers of BHK-21 cells as described by Gentsch & Bishop (1976) . In order to attain single-cycle growth conditions, together with efficient shut-off of host protein synthesis, a high multiplicity of infection (approx. 300) was used. Monolayers of BHK-21 cells were initially infected with LAC virus at a multiplicity of infection of 0,3. After incubating at 33 °C for 72 h the cell-released virus was concentrated from the culture medium by precipitation with polyethylene glycol 6000 and NaC1 (final concentrations of 70 g/l and 23 g/1 respectively). The precipitated virus was resuspended in a small volume of minimal essential medium (MEM) and used as the inoculum in the experiments described below. Polypeptides were radiolabelled with L-[4,5-3H]leucine at 6 h post-adsorption. Radiolabelling was for 1 h using [3H]leucine at a final concentration of 25 /aCi/ml in leucine-free MEM. Intracellular polypeptides were analysed by SDSpolyacrylamide gel electrophoresis, using either 7% or 10% polyacrylamide gels, as described previously (Cash et al., 1977) .
Under the conditions of high multiplicity of infection used in these experiments maximum 0022-1317/82/0000-4818 $02.00 © 1982 SGM titres of extracellular, infectious virus were obtained at 8 h post-adsorption. It was also observed that the polypeptides N and G 1 exhibited different rates of synthesis within the first 8 h of infection as previously reported by Pennington et al. (1977) for Bunyamwera virus (data not shown). The effect of monensin and tunicamycin on the release of infectious virus from BHK-21 cells infected at high multiplicity with LAC virus was examined (Table 1) . Infected cells were treated with either monensin (1/~M) or tunicamycin (2 #g/ml), commencing immediately after adsorption, or remained untreated. Unadsorbed virus was removed by washing the cell monolayers at 1 h post-adsorption. Untreated LAC virus-infected ceils showed a rise in titre of >100-fold during the course of the 8 h incubation period. In those cells treated with monensin, the progeny virus yields were reduced by over 99 %, compared to the control, by 8 h post-adsorption. In LAC virus-infected cells incubated in the presence of tunicamycin the progeny virus yields were reduced by over 95 % by 8 h post-adsorption. Monensin was also shown to inhibit the release of virus particles assayed by sucrose density-gradient analysis of culture media (Cash et al., 1980) 
from LAC virus-infected cells radiolabelled with [3H]leucine (data not shown).
The effect of monensin and tunicamycin on intracellular polypeptide synthesis of LAC virus-infected cells is shown in Fig. 1 . Cell lysates prepared from untreated LAC virus-infected cells showed two virion polypeptides, G1 and N, as major components (Fig.  1 a, lane 8) . The second virion glycoprotein, G2, was present as a minor component. Cell lysates prepared from cells treated with tunicamycin from 0 h post-adsorption showed one polypeptide co-migrating with N and another migrating in the region of GI when analysed on a 10% polyacrylamide gel (Fig. la, lane 4) . When analysed on a 7% polyacrylamide gel, however, the latter polypeptide was found to migrate ahead of G 1 present in untreated cell lysates ( Fig. 1 b, lane 3) . This polypeptide was considered to be comparable to G10 present in snowshoe hare virus-infected BHK-21 cells incubated jn the presence of tunicamycin (Cash et al., 1980) . No polypeptide was found to co-migrate with G2; neither was there any polypeptide migrating in the expected position of G20 (Fig. 1 a, lane 4) (Cash et al., 1980) . In cell lysates prepared from infected cells treated with tunicamycin from 4 h post-adsorption three polypeptides were identified, which had the same electrophoretic mobilities as G1, G2 and N (Fig. I a, lane 5) . Cell lysates prepared from LAC virus-infected cells treated with monensin from either 0 h or 1-5 h post-adsorption showed polypeptides co-migrating with G1, G2 and N (Fig. 1 a, lanes 6 and 7 respectively) . When analysed on a 7% polyacrylamide gel the G1 synthesized in the presence of monensin (present from 0 h post-adsorption) co-migrated with G1 synthesized in untreated control cells (Fig. I b, lane 4) . In this experiment the yield of infectious LAC virus in the culture medium was reduced by over 90 % for infected cells treated with monensin from either 0 h or 1.5 h post-adsorption compared with untreated infected cells. Analysis of cell lysates radiolabelled with [3H]mannose showed mannose to be associated with G1 in both the absence and presence of monensin, but not to be associated with the G10 polypeptide found in the presence of tunicamycin (data not shown).
The virus specificity of the G1 and G10 polypeptides, synthesized in the presence of monensin and tunicamycin respectively, was examined using immunoprecipitation with LAC virus antiserum and Staphylococcus aureus (Kessler, 1975; Cash et al., 1980) . Immunoprecipitated cell lysates were analysed on a 7 % polyacrylamide gel (Fig. 1 c) . The major polypeptide to be precipitated from infected cells was either G I from untreated and monensin-treated cells (Fig. 1 c, lanes 1 and 3 respectively) or GI 0 from tunicamycin-treated cells (Fig. I c, lane 2) . Polypeptides of lower electrophoretic mobility than G 1 were present in immunoprecipitates from LAC virus-infected and uninfected cells. These polypeptides represented non-specific precipitation since, unlike G 1 and G10, they were precipitated by the Staphylococcus in the absence of immune serum (data not shown).
As with VSV and SV, monensin blocked the release of LAC virus particles from infected cells as demonstrated by infectivity assays and sucrose density-gradient analysis on extracellular culture media. Solely by these parameters the activities of monensin and tunicamycin on virus replication were indistinguishable. Analysis of the virus-induced polypeptides, however, showed that the two drugs inhibited virus release by two distinct mechanisms. On the basis of electrophoretic mobility, mannose incorporation and immunoprecipitation the G1 and G2 polypeptides synthesized in the presence of monensin were indistinguishable from those present in untreated, infected cells. In contrast, when LAC virus-infected ceils were incubated for the same period of time in the presence of tunicamycin the non-glycosylated form of G1 (Gl0), but not the fully glycosylated G1, was identified. No polypeptide corresponding to G2 or G20 was identified. The synthesis of N was unaffected by either tunicamycin or monensin. Thus, the inhibition of virus maturation in the presence of monensin could not be directly attributed to a defect in polypeptide synthesis or processing as found with tunicamycin. Monensin interferes with the movement of material from the Golgi vesicles to the plasmalemma (Tartakoff & Vassalli, 1977 , 1978 . In the case of bunyaviruses this would interfere with the transport of virus particles, budding at the Golgi vesicle membrane, to the extracellular culture medium. It may be expected, therefore, that there would be an increase in the amount of cell-associated infectious virus present in monensin-treated ceils compared to untreated, infected cells. This was not borne out by experiment since in the presence of monensin, the infectious virus, associated with the cell, was reduced by over 95 % compared to untreated infected cells (data not shown). It is possible, therefore, that a virion maturation step exists, which is associated with the plasmalemma, subsequent to particle formation.
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